إعلان
إعلان

MNMD

MNMD logo

Mind Medicine (MindMed) Inc. Common Shares

14.03
USD
برعاية
+0.52
+3.82%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

13.86

-0.17
-1.18%

تقارير أرباح MNMD

النسبة الإيجابية المفاجئة

MNMD تفوق 10 من 20 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.52
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+26.83%

Mind Medicine (MindMed) Inc. Common Shares earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, MNMD reported earnings of -0.78 USD per share (EPS) for Q3 25, missing the estimate of -0.51 USD, resulting in a -52.55% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an نقصان of -33.33% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Mind Medicine (MindMed) Inc. Common Shares reported EPS of -$0.78, missing estimates by -52.55%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.17%, changed from $11.34 before the earnings release to $11.70 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 14 المحللين, Mind Medicine (MindMed) Inc. Common Shares is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان